Bing

SEARCH HISTORY

Jerusalem & Lund, Sweden - June 25, 2015 - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Active Biotech (NASDAQ Stockholm: ACTI) today announced that the patient enrollment for the pivotal Phase III CONCERTO trial has been …
Stock World · 6/25/2015
Active Biotech
In the biggest health-care deal proposed so far this year, Teva is offering a 50/50 combination of cash and stock for Mylan. The takeover would create the world’s top-selling generic-drug company with more than $30 billion in sales in 145 countries.
Wall Street Journal · ByJonathan D. Rockoff · 4/21/2015
MORGANTOWN — Teva Pharmaceutical Industries announced Friday morning, June 19, that it has purchased 4.61 percent of Mylan NV stock shares, which enables it to begin court proceedings before the Dutch Enterprise Chamber if that move becomes …
thedpost.com · 6/19/2015
More from Bing News
Teva Pharmaceutical Industries, Ltd., has been trying to buy fellow giant generic drugmaker Mylan, Inc., and the latest step to emerge was the purchase of chunks of stock on the open market. Teva said it had bought a 1.35% stake in Mylan at prices ranging ...
Philadelphia Daily News · 5/29/2015
who has a buy rating on the stock. Teva trades at 12 times 12-month future earnings, half the industry average, according to data compiled by Bloomberg. The shares have rallied 55 percent since 2013 and began trading above $60 this month. “The bulk of ...
Bloomberg · ByGabrielle Coppola · 3/28/2015
The pharmaceutical industry tends to be highly volatile, with significant downside susceptibility to recessions. For Teva, however, its stock has not seen a significant decline in value since 2008. And despite the massive drop in January-March 2014 when ...
Seeking Alpha · 1/1/2015
LOS ANGELES (MarketWatch) — One look at Mylan N.V..’s stock price on Tuesday morning and investors might get a clue as to what sort of chances Teva Pharmaceuticals Industries has of pulling off a union of two of the world’s top generic drug makers.
Market Watch · ByRuss Britt · 4/21/2015
At Stock Options Channel, our YieldBoost formula has looked up and down the TEVA options chain for the new July 10th contracts and identified one put and one call contract of particular interest. The put contract at the $60.00 strike price has a current ...
Forbes · 5/28/2015
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a proposal to acquire all of the outstanding shares of Mylan N.V. (NASDAQ: MYL) in a transaction valued at $82.00 per Mylan share, with …
Business Wire · 4/21/2015
saying it was too low and calling Teva stock an “unacceptable” currency. Teva, the world’s biggest maker of generic drugs, last week offered $82 per share in cash and stock for smaller rival Mylan. Mylan, which is pursuing its own takeover of Perrigo ...
Globe and Mail · 4/27/2015

Teva Pharmaceutical Industries

Company
Teva Pharmaceutical Industries Ltd. is an international pharmaceutical company headquartered in Petah Tikva, Israel. It specializes prim…
Teva Pharmaceutical Industries Ltd. is an international pharmaceutical company headquartered in Petah Tikva, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and to a lesser extent proprietary pharmaceuticals. It is the largest generic drug manufacturer in the world and one of the 15 largest pharmaceutical companies worldwide. Teva's facilities are located in Israel, North America, Europe, and South America. Teva is a member of both the New York Stock Exchange and the Tel Aviv Stock Exchange.
Data from: Wikipedia